Several criticisms of past attempts to produce experimental phenylketonuria are discussed, and a model that appears to meet these criticisms is presented. This model uses inhibition in rats of phenylalanine hydroxylase (EC 1.14.3.1) by p-chlorophenylalanine and supplementation with phenylalanine to produce a high ratio of phenylalanine to tyrosine in their blood. By this method, an experimental subject is produced whose behavioral, neurological, and biochemical characteristics are similar to those of clinical patients with phenylketonuria.
Experimental animal models of phenylketonuria have received much attention because this disorder is associated with a type of mental retardation whose origin is genetically and biochemically understood. A valid animal model would allow one to assess the relative value of various treatment methods and to study the mechanisms by which a specific metabolic abnormality result in brain damage and behavioral derangement. Many investigators have attempted to produce phenylketonuria in experimental animals but have had only limited success, perhaps because most of them have failed to define what constitutes a valid model of this type of disease or to state how well their model approximates the clinical disorder.
The five errors that seem to occur most frequently in experimental attempts to produce phenylketonuria, and which may explain the variability of results, are as follows. First there is the chemical method of producing the model. Most workers have given phenylalanine alone in large amounts to experimental animals (1, 2) . This method produces hyperphenylalaninemia, but fails to duplicate the high ratio of phenylalanine to tyrosine in blood or the absence of hepatic phenylalanine hydroxylase (EC 1.14.3.1) activity found in phenylketonuria. Some researchers have administered pchlorophenylalanine (3), an inhibitor of phenylalanine hydroxylase. However, without phenylalanine supplementation this method does not produce hyperphenylalaninemia in a rat, the most commonly used animal, because of the high levels of phenylalanine hydroxylase present in this species. Neither of these methods, therefore, duplicates the biochemical characteristics of phenylketonuria: hyperphenylalaninemia with normal or lowered tyrosine concentration in blood and the absence of phenylalanine hydroxylase. Intricate behavioral work should not be based on a faulty biochemical assumption of similarity to the intended clinical disorder. The second common error concerns the time in the life of the experimental subject in which the disorder is produced. Induced at any time past the phase of rapid brain development, selective hyperphenylalaninemia certainly affects the brain differently than when such a condition is present during 863 with ClPhe, and simultaneously administering phenylalanine, to give a high phenylalanine to tyrosine ratio in plasma and low activity of hepatic phenylalanine hydroxylase. This method was suggested by Lipton, Gordon, Guroff, and Udenfriend, who presented data showing that such a program produces the biochemical characteristics of. phenylketonuria (9) . (b) The treatment period began at birth and continued daily for 21 days, during which time the major development of rat brain occurs. (c) The animals were tested when mature, after a long recovery period of about 6 months. (d) To appreciate the global nature of the disorder, the subjects motor activity, autonomic activity, active and passive avoidance abilities, learning ability, and aggression were tested. (e) Finally, an attempt has been made to correlate behavioral changes with abnormalities in brain structure. Injections were given daily for 21 consecutive days after birth. Pups were weaned when they were about 30 days old, and were maintained thereafter on food pellets and water ad lib. They were kept in their litter groups until 6 weeks of age, when they were separated by sex. Before they were tested at about 7 months of age, subjects were placed in individual cages in which they were maintained throughout the testing period.
Method for behavior testing
The overall testing plan was as follows. The same subjects were used in all tests in order that intertest comparisons could be made. Predominantly observational tests were done first. Males were then tested for active and passive avoidance, and females for appetitive learning. Finally, subjects were recombined for aggression testing and brain examination. Wherever possible visual cues were avoided because of reports (10) that ClPhe induces cataracts.
Open-Field Test for Motor Activity. Subjects were 12 male and 8 female animals treated with saline, 7 male and 9 female rats treated with phenylalanine, and 12 male and 8 female rats treated with p-chlorophenylalanine plus phenylalanine.
The open-field apparatus (91 X 51 cm) was divided by thin black lines into areas of 15 X 17 cm. Each rat was introduced nose first into a corner; the number of boundaries crossed over the next 5 min was recorded.
Open-Field Test for Fecal Pellets. After each open-field test for motor activity, fecal pellets were counted. The number of fecal pellets deposited on an open field has been used as one index of automatic activity, emotionality, and general reactivity to a stress situation. The important feature of this test is that fecal pellets represent a relatively constant and enduring measure of an animal's response to a novel environment. The response to constraint was tested by reintroduction of the subject back into the open field, but confined to one corner by a Plexiglas column. Fecal pellets were counted after confinement for 5 min.
Active Avoidance with Two-Way Shuttlebox (C.H. Stoelting Co., Chicago). Subjects were 9 male rats treated with saline, 6 with phenylalanine, and 6 with phenylalanine plus p-ClPhe. This test used a two-way shuttlebox, of dimensions 48 X 21 X 28 cm, with a floor of stainless steel bars and a central doorway between compartments. Before the first session, each animal explored the apparatus for 10 min. There is a significant difference between saline and ClPhe+Phe. Phe treatment falls between saline and ClPhe+ of combined buzzer and shock (average bar current, 0.7 mA). The task presented to the animal was to cross through the central doorway after the buzzer was sounded in order to avoid a shock. Passive Avoidance of a Previously Learned Active Avoidance Response. The same subjects and apparatus described in active avoidance were used. 24 Hr before passive avoidance testing, each subject was given one repeat session of 30 trials of active avoidance to minimize differences in memory of the active avoidance task. The two-way shuttlebox was then modified for passive avoidance testing. One side (side A) was unchanged. The other side (side B) was converted into a small enclosed area of 17 X 13 X 10 cm, opening directly off the central partition doorway, with free access between sides A and B. The task for the subject was to inhibit his previously learned active response of moving on buzzer presentation. The criterion for passive avoidance learning was defined as the number of trials required for a subject, introduced into side A, to learn to sit through four successive buzzer presentations without moving to side B. Parameters of time, buzzer loudness, and extent of shock were the same as above. If the subject moved to side B on buzzer presentation, he was shocked, removed to a holding box for 1 min, and returned to side A. 1 Week after determination of the number of trials required to reach the passive avoidance criterion, subjects were tested for the number of trials to relearn the same criterion. At this time, latency to move, defined as the number of buzzer presentations sat through before moving on the first trial, was also determined.
T-Maze Testing (Appetitive Learning). 6 Female rats treated with saline, 8 with phenylalanine, and 7 with ClPhe+ Phe were accustomed to a water deprivation schedule of 1 hr of drinking time per day. As preparation for T-maze testing, rats were allowed to explore the T-maze and were trained to run for a water reward at the ends of the bar of the T. A piece of sandpaper 38 cm long by 10 cm wide was placed in the runway portion of the maze. The learning task consisted of associating the rough surface of the sandpaper with a right turn to a water reward, and the smooth side of the sandpaper with a left turn for a water reward. If all choices were incorrect at the end of a testing session, the subject was allowed to self-correct on the last trial. Trials per day were gradually increased from three to seven, with time per trial allowed at the choice point decreased from 5 min to 90 sec.
Aggression Testing. One adult male mouse was introduced into each rat home cage. Mouse killing was noted after 5 min and after 1 hr. Male rats were retested for mouse killing after they received four ascending shocks: 0.2, 0.5, 0.8, and 1.6 mA. These shocks were administered to determine the behavioral response to different shock levels.
Method of brain examination Brain Weights. Each rat received intraperitoneally 100 units of heparin and 50 mg of pentobarbital, and was then decapitated and its brain was weighed.
Methods for Neuropathology. Subjects for neuropathology were anesthetized and perfused with heparinized saline, followed by 10% formalin. (Fig. 1) . On all observations, rats treated with ClPhe+Phe were more active than the controls. With one exception, rats treated with phenylalanine alone fell between those treated with ClPhe+Phe and saline. For males, the difference between ClPhe+Phe and saline groups is significant both on individual trials (P < 0.05, Wilcoxon test) and when the sums of scores on all three trials are compared (P < 0.011). The difference between females treated with ClPhe+Phe and saline does not reach statistical significance, although the trend is clearly in that direction. As in most other open-field tests, female rats were more active than male rats. Open-Field Fecal Pellets As an Index of Autonomic Activity. When the sums of fecal pellets expelled on all three trials are compared, saline controls exhibited more autonomic activity than treated animals (P < 0.04). In the 5-min long mildconfinement situation conducted on the same apparatus, saline-treated animals showed considerably more autonomic activity than treated rats (P < 0.004). Animals given phenylalanine alone give intermediate results between controls and those treated with ClPhe+Phe.
Active Avoidance Response (Fig. 2) . There is no statistically significant difference between any groups in active-avoidance learning ability.
Passive Avoidance Response (Fig. 2) . Treated animals required nearly twice as many trials as did saline-treated controls to achieve criterion performance on initial passiveavoidance testing (P < 0.035). When criterion testing was repeated 1 week later, a disparity between these two groups persisted (P < 0.012). On the first trial at the repeat testing, the treated animals ran after 1.2 buzzer presentations, compared with saline-treated animals, who sat through 2.4 buzzer presentations before moving to side B. The difference in the latency period between treated and control rats is significant (P < 0.015).
T-Maze. This experiment did not show what it was intended to show: a comparison of the rate of appetitive learning in a water-deprived animal in a T-maze. No group achieved greater than a chance score of correct choices, the task apparently being too difficult even for the normal rats. What did appear significant was that the treated animals showed more no-choice events; that is, they more frequently came to for myelin.
Proc. Nat. Acad. Sci. USA 69 (1972) the choice point of the maze and refused to move in either When rats were tested immediately after shock, no new mouse killers emerged. Although treated rats killed more mice, these numbers are not statistically significant.
Neuropathology
Brain Weihts. (Table 1 ). There is no statistically significant difference between body weights of the three groups when all possible combinations are considered. The brain weights of the saline-and Phe-treated groups do not differ from each other, but are both very significantly heavier than those of rats treated with ClPhe+Phe. For the males: Saline against ClPhe+Phe, P < 0.002; Phe against ClPhe+Phe, P < 0.001. For the females: Saline against ClPhe+Phe, P < 0.0005; Phe against ClPhe+Phe, P < 0.0005.
Histology. When compared with saline-treated controls, brains from rats treated with ClPhe+Phe do not show any focal myelin defects. There is a suggestion of lighter myelin staining in the ClPhe+Phe brains, but the difference is slight and may not be significant. The most severe myelin defects associated with phenylketonuria are found in young patients (11) , with progressively fewer findings observed on neuropathological examination as brains from older patients are examined.
DISCUSSION
This paper reports initial observations on an animal model of phenylketonuria and offers some practical suggestions to assess its validity. Our goal is an animal model valid at the biochemical, neurophysiological, neuropathological, and behavioral levels. the FIG. 2 . Active avoidance training, followed by passive avoidance of the active response. Left: the scores of male subjects over 10 sessions of active avoidance in a two-way shuttlebox. Each session consisted of 30 trials. There is no significant difference between groups on active avoidance testing. Right: the response of these same subjects (excluding Phe) to passive avoidance of the learned active avoidance response. The saline-treated and ClPhe+ Phe-treated animals now split into two distinct groups; the statistically significant difference between groups is maintained when the subjects are retested 1 week later. The results of the first passive avoidance sessions are 6.6 i 1.1 trials for controls and 11.2 ± 1.8 trials for ClPhe+Phe-treated rats (standard error given). The results of the repeat passive avoidance session are 1.7 i 0.2 trials for controls and 2.6 i 0.3 trials for treated. results of experimental phenylketonuria should be contrasted with those of experimental malnutrition, since the actual agent of injury in experimental phenylketonuria might plausibly be an undernourishment secondary to the noxious effects of the injections. When this comparison is made, subjects with experimental malnutrition are noted to be less active, not more active, than normal rats when they are refed (13) and are permanently decreased in weight (14) . Another question is whether our model produces in the experimental subject changes not found in clinical phenylketonuria. For example, cataracts sometimes occur after administration of ClPhe to rats. This represents an experimental change not found in clinical phenylketonuria. ClPhe partially inhibits tryptophan hydroxylase activity, which results in lowered serotonin concentrations. This might be considered another example of an unwanted characteristic found in the model system, but not in the clinical situation. However, phenylketonuria is associated with decreased* serotonin concentrations, so in this regard the model system duplicates a biochemical characteristic of clinical phenylketonuria, rather than creating an unwanted novel effect.
Our own criteria suggest several improvements that should be made in our model. These improvements include the development of learning tasks that more effectively distinguish between experimental and control animals, a comparison of this model with others involving different types of brain damage, and a detailed study of the developmental neuropathology of our model. We feel that these efforts to achieve a valid model of phenylketonuria are worthwhile. In the field of brain-behavior research, the interaction between such a complex organ as the brain, which constantly changes in structure and function during its development, and illdefined types of neurological injury produces a wide range of adult behavior and brain damage. By carefully exposing the developing brain to a well-defined metabolic error, this interaction may be simplified so that specific questions about the mechanism of brain damage and the resultant behavioral 
